Advertisement
Screener

CUBIST PHARMACEUTICALS INC Selling, General and Administrative Expense

CUBIST PHARMACEUTICALS INC Selling, General and Administrative Expense

CUBIST PHARMACEUTICALS INC reported Selling, General and Administrative Expense of $77.79 million for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-11-07.

Discontinued › Expense Statement › Operating Expenses

us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2014-11-07

  • CUBIST PHARMACEUTICALS INC selling, general and administrative expense for the quarter ending 2014-09-30 was $77.79M, a 5.33% increase year-over-year.
  • CUBIST PHARMACEUTICALS INC selling, general and administrative expense for the quarter ending 2014-06-30 was $80.06M, a 60.47% increase year-over-year.
  • CUBIST PHARMACEUTICALS INC selling, general and administrative expense for the quarter ending 2014-03-31 was $69.66M, a 44.52% increase year-over-year.
  • CUBIST PHARMACEUTICALS INC selling, general and administrative expense for the quarter ending 2013-12-31 was $86.00M, a 81.68% increase year-over-year.
  • CUBIST PHARMACEUTICALS INC selling, general and administrative expense for fiscal 2013 was $257.94M, a 50.15% increase from fiscal 2012.
  • CUBIST PHARMACEUTICALS INC selling, general and administrative expense for fiscal 2012 was $171.79M, a 5.24% increase from fiscal 2011.
  • CUBIST PHARMACEUTICALS INC selling, general and administrative expense for fiscal 2011 was $163.23M, a 13.87% increase from fiscal 2010.
  • CUBIST PHARMACEUTICALS INC selling, general and administrative expense for fiscal 2010 was $143.34M, a 4.69% increase from fiscal 2009.
Period endSelling, General and Administrative Expense 3 monthSelling, General and Administrative Expense 3 month as first filedSelling, General and Administrative Expense 6 monthSelling, General and Administrative Expense 9 monthSelling, General and Administrative Expense 9 month as first filedSelling, General and Administrative Expense 12 month
2014-09-30$77.79M
10-Q · filed 2014-11-07
$157.85M
derived: sum of 2 quarters · filed 2014-11-07
$227.51M
10-Q · filed 2014-11-07
$313.50M
derived: sum of 4 quarters · filed 2014-11-07
2014-06-30$80.06M
10-Q · filed 2014-08-11
$149.72M
10-Q · filed 2014-08-11
$235.71M
derived: sum of 3 quarters · filed 2014-08-11
$309.57M
derived: sum of 4 quarters · filed 2014-11-07
2014-03-31$69.66M
10-Q · filed 2014-05-02
$155.66M
derived: sum of 2 quarters · filed 2014-05-02
$229.51M
derived: sum of 3 quarters · filed 2014-11-07
$279.40M
derived: sum of 4 quarters · filed 2014-11-07
2013-12-31$86.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25
$159.85M
derived: sum of 2 quarters · filed 2014-11-07
$209.74M
derived: sum of 3 quarters · filed 2014-11-07
$257.94M
10-K · filed 2014-02-25
2013-09-30$73.86M
10-Q · filed 2014-11-07
$74.88M
10-Q · filed 2013-11-12
$123.74M
derived: sum of 2 quarters · filed 2014-11-07
$171.94M
10-Q · filed 2014-11-07
$172.97M
10-Q · filed 2013-11-12
$219.28M
derived: sum of 4 quarters · filed 2014-11-07
2013-06-30$49.89M
10-Q · filed 2014-08-11
$98.09M
10-Q · filed 2014-08-11
$145.42M
derived: sum of 3 quarters · filed 2014-08-11
$185.84M
derived: sum of 4 quarters · filed 2014-08-11
2013-03-31$48.20M
10-Q · filed 2014-05-02
$95.53M
derived: sum of 2 quarters · filed 2014-05-02
$135.95M
derived: sum of 3 quarters · filed 2014-05-02
$176.21M
derived: sum of 4 quarters · filed 2014-05-02
2012-12-31$47.33M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25
$87.75M
derived: sum of 2 quarters · filed 2014-02-25
$128.01M
derived: sum of 3 quarters · filed 2014-02-25
$171.79M
10-K · filed 2014-02-25
2012-09-30$40.42M
10-Q · filed 2013-11-12
$80.67M
derived: sum of 2 quarters · filed 2013-11-12
$124.45M
10-Q · filed 2013-11-12
$173.23M
derived: sum of 4 quarters · filed 2014-02-25
2012-06-30$40.26M
10-Q · filed 2013-08-06
$84.03M
10-Q · filed 2013-08-06
$132.81M
derived: sum of 3 quarters · filed 2014-02-25
$168.76M
derived: sum of 4 quarters · filed 2014-02-25
2012-03-31$43.78M
10-Q · filed 2013-05-07
$92.55M
derived: sum of 2 quarters · filed 2014-02-25
$128.50M
derived: sum of 3 quarters · filed 2014-02-25
$166.84M
derived: sum of 4 quarters · filed 2014-02-25
2011-12-31$48.77M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25
$84.72M
derived: sum of 2 quarters · filed 2014-02-25
$123.06M
derived: sum of 3 quarters · filed 2014-02-25
$163.23M
10-K · filed 2014-02-25
2011-09-30$35.95M
10-Q · filed 2012-11-05
$74.29M
derived: sum of 2 quarters · filed 2012-11-05
$114.45M
10-Q · filed 2012-11-05
$151.29M
derived: sum of 4 quarters · filed 2013-02-27
2011-06-30$38.34M
10-Q · filed 2012-08-07
$78.50M
10-Q · filed 2012-08-07
$115.34M
derived: sum of 3 quarters · filed 2013-02-27
$150.22M
derived: sum of 4 quarters · filed 2013-02-27
2011-03-31$40.16M
10-Q · filed 2012-05-01
$77.00M
derived: sum of 2 quarters · filed 2013-02-27
$111.88M
derived: sum of 3 quarters · filed 2013-02-27
$148.92M
derived: sum of 4 quarters · filed 2013-02-27
2010-12-31$36.84M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27
$71.71M
derived: sum of 2 quarters · filed 2013-02-27
$108.76M
derived: sum of 3 quarters · filed 2013-02-27
$143.34M
10-K · filed 2013-02-27
2010-09-30$34.87M
10-Q · filed 2011-11-02
$71.92M
derived: sum of 2 quarters · filed 2011-11-02
$106.50M
10-Q · filed 2011-11-02
2010-06-30$37.05M
10-Q · filed 2011-07-29
$71.63M
10-Q · filed 2011-07-29
2010-03-31$34.58M
10-Q · filed 2011-04-29
2009-12-31$136.92M
10-K · filed 2012-02-27